Cargando…
Efficacy of Topical Carbonic Anhydrase Inhibitors in Reducing Duration of Chronic Central Serous Chorioretinopathy
PURPOSE: Topical carbonic anhydrase inhibitors (CAIs) can influence retinal fluid distribution, but their role in treating central serous chorioretinopathy (CSCR) has not been studied. We examined the efficacy of a topical CAI (dorzolamide) in treating chronic CSCR. METHODS: Prospective, nonrandomiz...
Autores principales: | Liew, Gerald, Ho, I-Van, Ong, Stephen, Gopinath, Bamini, Mitchell, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718817/ https://www.ncbi.nlm.nih.gov/pubmed/33344050 http://dx.doi.org/10.1167/tvst.9.13.6 |
Ejemplares similares
-
Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani, Sepehr, et al.
Publicado: (2019) -
Topical Nepafenac in Treatment of Acute Central Serous Chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2013) -
ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration
por: Daruich, Alejandra, et al.
Publicado: (2017) -
The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021) -
Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)